|
C1ORF112 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.4711999941095E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.50609996591089E-09 |
| Normal-vs-Stage2 |
1.190350E-04 |
| Normal-vs-Stage3 |
1.65903999999051E-05 |
| Normal-vs-Stage4 |
5.15740000039955E-07 |
| Stage1-vs-Stage2 |
8.043000E-01 |
| Stage1-vs-Stage3 |
2.652000E-01 |
| Stage1-vs-Stage4 |
2.561600E-01 |
| Stage2-vs-Stage3 |
5.665600E-01 |
| Stage2-vs-Stage4 |
2.634800E-01 |
| Stage3-vs-Stage4 |
6.617900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.41899952793767E-10 |
| Normal-vs-AfricanAmerican |
1.512010E-02 |
| Normal-vs-Asian |
7.034700E-04 |
| Caucasian-vs-AfricanAmerican |
9.730600E-01 |
| Caucasian-vs-Asian |
3.211400E-01 |
| AfricanAmerican-vs-Asian |
6.078000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.94570004552475E-09 |
| Normal-vs-Female |
2.4086999950157E-08 |
| Male-vs-Female |
6.450800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.935740E-03 |
| Normal-vs-Age(41-60Yrs) |
1.3283999455993E-09 |
| Normal-vs-Age(61-80Yrs) |
6.13149999661999E-08 |
| Normal-vs-Age(81-100Yrs) |
3.523800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.794000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.240240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.485850E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.610600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.634600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.692800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.965400E-04 |
| Normal-vs-Grade 2 |
5.96149996034967E-09 |
| Normal-vs-Grade 3 |
1.62349999999201E-07 |
| Normal-vs-Grade 4 |
2.05919999999304E-05 |
| Grade 1-vs-Grade 2 |
4.293000E-01 |
| Grade 1-vs-Grade 3 |
4.422600E-01 |
| Grade 1-vs-Grade 4 |
7.911800E-01 |
| Grade 2-vs-Grade 3 |
9.456400E-01 |
| Grade 2-vs-Grade 4 |
3.328200E-01 |
| Grade 3-vs-Grade 4 |
3.081800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.30789975808455E-10 |
| Normal-vs-ccB subtype |
5.76949999997467E-08 |
| ccA subtype-vs-ccB subtype |
9.815800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.50760001652139E-09 |
| Normal-vs-N1 |
2.055900E-03 |
| N0-vs-N1 |
8.275900E-02 |
|
|
